New CAR T-Cell Therapy Finds Niche in R/R Mantle Cell Lymphoma New CAR T-Cell Therapy Finds Niche in R/R Mantle Cell Lymphoma

A single infusion of a new form of CAR T-cell therapy induces durable remissions in relapsed/refractory mantle cell lymphoma following BKT failure.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news